Latent tuberculosis (English Wikipedia)

Clinical trial number NCT01582711 for "Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT (iAdhere)" at ClinicalTrials.gov

democraticunderground.com

"CDC issues Important info about TB exposure, explains tests here". Democratic Underground. Archived from the original on 2015-09-30. Retrieved 2015-10-05.

doi.org

Jasmer R.M., Nahid P., Hopewell P.C. (2002). "Clinical practice. Latent tuberculosis infection" (PDF). The New England Journal of Medicine. 347 (23): 1860–1866. doi:10.1056/NEJMcp021045. ISSN 0028-4793. PMID 12466511. Archived from the original (PDF) on 2011-02-24.
Kelly E. Dooley; Tania Tang; Jonathan E. Golub; Susan E. Dorman; Wendy Cronin (2009). "Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis". American Journal of Tropical Medicine and Hygiene. 80 (4): 634–639. doi:10.4269/ajtmh.2009.80.634. PMC 2750857. PMID 19346391.
Comstock, George W; Livesay, Verna T; Woolpert, Shirley F (1974). "The prognosis of a positive tuberculin reaction in childhood and adolescence". American Journal of Epidemiology. 99 (2): 131–8. doi:10.1093/oxfordjournals.aje.a121593. PMID 4810628.
Heaf, Frederick (July 1951). "The Multiple-Puncture Tuberculin Test". The Lancet. 258 (6674): 151–153. doi:10.1016/S0140-6736(51)91399-2. PMID 14851705.
Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). "Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts". Am J Respir Crit Care Med. 173 (8): 922–6. doi:10.1164/rccm.200512-1953OC. PMC 2662911. PMID 16474028.
Timothy R. Sterling; M. Elsa Villarino; Andrey S. Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E. Weis; Marc Weiner; Diane Wing; Marcus B. Conde; Lorna Bozeman; C. Robert Horsburgh, Jr.; Richard E. Chaisson (2011). "Three months of rifapentine and isoniazid for latent tuberculosis infection". New England Journal of Medicine. 365 (23): 2155–2166. doi:10.1056/NEJMoa1104875. PMID 22150035. S2CID 36515489.
Flynn, J. L.; Chan, J. (2001). "Tuberculosis: Latency and Reactivation". Infection and Immunity. 69 (7): 4195–201. doi:10.1128/IAI.69.7.4195-4201.2001. PMC 98451. PMID 11401954.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (August 23, 2018). "Revisiting the timetable of tuberculosis". BMJ (Clinical Research Ed.). 362: k2738. doi:10.1136/bmj.k2738. ISSN 1756-1833. PMC 6105930. PMID 30139910.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (2024). "Rethinking the burden of latent tuberculosis to reprioritize research". Nature Microbiology. 9 (5): 1157–1158. doi:10.1038/s41564-024-01683-0. PMID 38671272.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (2019-10-24). "Is Mycobacterium tuberculosis infection life long?". BMJ. 367: l5770. doi:10.1136/bmj.l5770. ISSN 0959-8138. PMC 6812595. PMID 31649096.

drweil.com

"Does Latent TB Need Treatment? – Ask Dr. Weil". Drweil.com. 2011-08-16. Archived from the original on 2015-09-23. Retrieved 2015-10-05.

ethnomed.org

"Latent TB: FAQ's — EthnoMed". Ethnomed.org. Archived from the original on 2016-01-15. Retrieved 2015-10-05.

idf.org

"Diabetes and tuberculosis". idf.org. International Diabetes Federation. Archived from the original on August 27, 2013. Retrieved September 5, 2013.

ijmr.org.in

Menzies, Dick; Al Jahdali, Hamdan; Al Otaibi, Badriah (2011). "Recent developments in treatment of latent tuberculosis infection". The Indian Journal of Medical Research. 133 (3): 257–66. PMC 3103149. PMID 21441678.

jasoncartermd.com

Jasmer R.M., Nahid P., Hopewell P.C. (2002). "Clinical practice. Latent tuberculosis infection" (PDF). The New England Journal of Medicine. 347 (23): 1860–1866. doi:10.1056/NEJMcp021045. ISSN 0028-4793. PMID 12466511. Archived from the original (PDF) on 2011-02-24.

latimes.com

Maugh II, Thomas H. (2011-05-17). "Shorter treatment found for latent tuberculosis". Los Angeles Times. Archived from the original on 2022-08-19. Retrieved 2019-10-29. Although TB control measures in the United States have brought the incidence of the disease to an all-time low of 11,181 cases in 2010, it is estimated that at least 11 million Americans have latent TB. 'The 11 million Americans with latent TB represent a ticking time bomb,' Dr. Kenneth Castro, director of the Centers for Disease Control and Prevention's division of tuberculosis elimination, said at a news conference Monday. 'They're the source of future TB cases.'

livescience.com

"Doctors Report Tuberculosis Now 'Virtually Untreatable' | Incurable TB Antibiotics". Livescience.com. 2013-02-12. Archived from the original on 2015-10-04. Retrieved 2015-10-05.

lung.org

"Tuberculosis Symptoms, Causes & Risk Factors". American Lung Association. Archived from the original on 2015-09-06. Retrieved 2015-10-05.

mass.gov

"Booster Phenomenon". Mass.gov. Archived from the original on 2015-10-06. Retrieved 2015-10-05.

mayoclinic.com

"Tuberculosis". Mayo Clinic. 2014-08-01. Archived from the original on 2012-12-27. Retrieved 2015-10-05.

medscape.com

emedicine.medscape.com

Tuberculosis at eMedicine

nature.com

Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (2024). "Rethinking the burden of latent tuberculosis to reprioritize research". Nature Microbiology. 9 (5): 1157–1158. doi:10.1038/s41564-024-01683-0. PMID 38671272.

nih.gov

pubmed.ncbi.nlm.nih.gov

Jasmer R.M., Nahid P., Hopewell P.C. (2002). "Clinical practice. Latent tuberculosis infection" (PDF). The New England Journal of Medicine. 347 (23): 1860–1866. doi:10.1056/NEJMcp021045. ISSN 0028-4793. PMID 12466511. Archived from the original (PDF) on 2011-02-24.
Kelly E. Dooley; Tania Tang; Jonathan E. Golub; Susan E. Dorman; Wendy Cronin (2009). "Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis". American Journal of Tropical Medicine and Hygiene. 80 (4): 634–639. doi:10.4269/ajtmh.2009.80.634. PMC 2750857. PMID 19346391.
Comstock, George W; Livesay, Verna T; Woolpert, Shirley F (1974). "The prognosis of a positive tuberculin reaction in childhood and adolescence". American Journal of Epidemiology. 99 (2): 131–8. doi:10.1093/oxfordjournals.aje.a121593. PMID 4810628.
Heaf, Frederick (July 1951). "The Multiple-Puncture Tuberculin Test". The Lancet. 258 (6674): 151–153. doi:10.1016/S0140-6736(51)91399-2. PMID 14851705.
Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). "Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts". Am J Respir Crit Care Med. 173 (8): 922–6. doi:10.1164/rccm.200512-1953OC. PMC 2662911. PMID 16474028.
Timothy R. Sterling; M. Elsa Villarino; Andrey S. Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E. Weis; Marc Weiner; Diane Wing; Marcus B. Conde; Lorna Bozeman; C. Robert Horsburgh, Jr.; Richard E. Chaisson (2011). "Three months of rifapentine and isoniazid for latent tuberculosis infection". New England Journal of Medicine. 365 (23): 2155–2166. doi:10.1056/NEJMoa1104875. PMID 22150035. S2CID 36515489.
Menzies, Dick; Al Jahdali, Hamdan; Al Otaibi, Badriah (2011). "Recent developments in treatment of latent tuberculosis infection". The Indian Journal of Medical Research. 133 (3): 257–66. PMC 3103149. PMID 21441678.
Flynn, J. L.; Chan, J. (2001). "Tuberculosis: Latency and Reactivation". Infection and Immunity. 69 (7): 4195–201. doi:10.1128/IAI.69.7.4195-4201.2001. PMC 98451. PMID 11401954.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (August 23, 2018). "Revisiting the timetable of tuberculosis". BMJ (Clinical Research Ed.). 362: k2738. doi:10.1136/bmj.k2738. ISSN 1756-1833. PMC 6105930. PMID 30139910.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (2024). "Rethinking the burden of latent tuberculosis to reprioritize research". Nature Microbiology. 9 (5): 1157–1158. doi:10.1038/s41564-024-01683-0. PMID 38671272.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (2019-10-24). "Is Mycobacterium tuberculosis infection life long?". BMJ. 367: l5770. doi:10.1136/bmj.l5770. ISSN 0959-8138. PMC 6812595. PMID 31649096.

ncbi.nlm.nih.gov

"Chapter 3—The Facts About Tuberculosis". Chapter 3—The Facts About Tuberculosis – The Tuberculosis Epidemic – NCBI Bookshelf. Ncbi.nlm.nih.gov. 1995. Archived from the original on 2016-01-15. Retrieved 2015-10-05.
Kelly E. Dooley; Tania Tang; Jonathan E. Golub; Susan E. Dorman; Wendy Cronin (2009). "Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis". American Journal of Tropical Medicine and Hygiene. 80 (4): 634–639. doi:10.4269/ajtmh.2009.80.634. PMC 2750857. PMID 19346391.
Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). "Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts". Am J Respir Crit Care Med. 173 (8): 922–6. doi:10.1164/rccm.200512-1953OC. PMC 2662911. PMID 16474028.
Menzies, Dick; Al Jahdali, Hamdan; Al Otaibi, Badriah (2011). "Recent developments in treatment of latent tuberculosis infection". The Indian Journal of Medical Research. 133 (3): 257–66. PMC 3103149. PMID 21441678.
Flynn, J. L.; Chan, J. (2001). "Tuberculosis: Latency and Reactivation". Infection and Immunity. 69 (7): 4195–201. doi:10.1128/IAI.69.7.4195-4201.2001. PMC 98451. PMID 11401954.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (August 23, 2018). "Revisiting the timetable of tuberculosis". BMJ (Clinical Research Ed.). 362: k2738. doi:10.1136/bmj.k2738. ISSN 1756-1833. PMC 6105930. PMID 30139910.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (2019-10-24). "Is Mycobacterium tuberculosis infection life long?". BMJ. 367: l5770. doi:10.1136/bmj.l5770. ISSN 0959-8138. PMC 6812595. PMID 31649096.

niaid.nih.gov

"Detailed Explanation of Tuberculosis (TB)". Niaid.nih.gov. 2009-03-06. Archived from the original on 2010-04-11. Retrieved 2015-10-05.

nytimes.com

health.nytimes.com

[1] Archived October 21, 2013, at the Wayback Machine

nytimes.com

McNeil, Donald G. Jr. (20 September 2018). "'Latent' tuberculosis? It's not that common, experts find". The New York Times. Archived from the original on 17 August 2022. Retrieved 13 March 2020.

patient.co.uk

"Risk Factors". The Mayo Clinic. July 12, 2013. Archived from the original on April 7, 2014. Retrieved September 5, 2013.
"Tuberculosis | Doctor". Patient. 2014-05-21. Archived from the original on 2014-04-07. Retrieved 2015-10-05.

semanticscholar.org

api.semanticscholar.org

Timothy R. Sterling; M. Elsa Villarino; Andrey S. Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E. Weis; Marc Weiner; Diane Wing; Marcus B. Conde; Lorna Bozeman; C. Robert Horsburgh, Jr.; Richard E. Chaisson (2011). "Three months of rifapentine and isoniazid for latent tuberculosis infection". New England Journal of Medicine. 365 (23): 2155–2166. doi:10.1056/NEJMoa1104875. PMID 22150035. S2CID 36515489.

tspot.com

"How the T-SPOT.TB Test Works". Archived from the original on 2020-02-04. Retrieved 2012-09-25.

umm.edu

"Tuberculosis | University of Maryland Medical Center". Umm.edu. 2015-03-24. Archived from the original on 2015-10-04. Retrieved 2015-10-05.

urldefense.com

Wu, Katherine J. (2023). "A big misconception about the world's greatest infectious killer". The Atlantic.

web.archive.org

Jasmer R.M., Nahid P., Hopewell P.C. (2002). "Clinical practice. Latent tuberculosis infection" (PDF). The New England Journal of Medicine. 347 (23): 1860–1866. doi:10.1056/NEJMcp021045. ISSN 0028-4793. PMID 12466511. Archived from the original (PDF) on 2011-02-24.
"Tuberculosis". World Health Organization. 2007. Archived from the original on 2009-11-11.
"Detailed Explanation of Tuberculosis (TB)". Niaid.nih.gov. 2009-03-06. Archived from the original on 2010-04-11. Retrieved 2015-10-05.
"CDC issues Important info about TB exposure, explains tests here". Democratic Underground. Archived from the original on 2015-09-30. Retrieved 2015-10-05.
"Chapter 3—The Facts About Tuberculosis". Chapter 3—The Facts About Tuberculosis – The Tuberculosis Epidemic – NCBI Bookshelf. Ncbi.nlm.nih.gov. 1995. Archived from the original on 2016-01-15. Retrieved 2015-10-05.
"Tuberculosis | University of Maryland Medical Center". Umm.edu. 2015-03-24. Archived from the original on 2015-10-04. Retrieved 2015-10-05.
"Latent TB: FAQ's — EthnoMed". Ethnomed.org. Archived from the original on 2016-01-15. Retrieved 2015-10-05.
"WHO | Tuberculosis". Who.int. 2015-03-09. Archived from the original on 2012-08-23. Retrieved 2015-10-05.
"Tuberculosis Symptoms, Causes & Risk Factors". American Lung Association. Archived from the original on 2015-09-06. Retrieved 2015-10-05.
"Diabetes and tuberculosis". idf.org. International Diabetes Federation. Archived from the original on August 27, 2013. Retrieved September 5, 2013.
"Risk Factors". The Mayo Clinic. July 12, 2013. Archived from the original on April 7, 2014. Retrieved September 5, 2013.
"Tuberculosis | Doctor". Patient. 2014-05-21. Archived from the original on 2014-04-07. Retrieved 2015-10-05.
"Tuberculosis". Mayo Clinic. 2014-08-01. Archived from the original on 2012-12-27. Retrieved 2015-10-05.
"CDC | TB | Testing & Diagnosis". Cdc.gov. Archived from the original on 2022-07-05. Retrieved 2015-10-05.
[1] Archived October 21, 2013, at the Wayback Machine
"Booster Phenomenon". Mass.gov. Archived from the original on 2015-10-06. Retrieved 2015-10-05.
"CDC | TB | Fact Sheets – Tuberculin Skin Testing for TB". Cdc.gov. 2012-09-01. Archived from the original on 2017-01-09. Retrieved 2015-10-05.
"CDC | TB | LTBI – Diagnosis of Latent TB Infection". Cdc.gov. Archived from the original on 2015-10-01. Retrieved 2015-10-05.
"How the T-SPOT.TB Test Works". Archived from the original on 2020-02-04. Retrieved 2012-09-25.
"CDC | TB | Fact Sheets | Multidrug-Resistant Tuberculosis (MDR TB)". Cdc.gov. Archived from the original on 2015-10-03. Retrieved 2015-10-05.
"CDC | TB | Fact sheets | Extensively Drug-Resistant Tuberculosis (XDR TB)". Cdc.gov. 2013-01-18. Archived from the original on 2019-04-12. Retrieved 2015-10-05.
"Doctors Report Tuberculosis Now 'Virtually Untreatable' | Incurable TB Antibiotics". Livescience.com. 2013-02-12. Archived from the original on 2015-10-04. Retrieved 2015-10-05.
"Does Latent TB Need Treatment? – Ask Dr. Weil". Drweil.com. 2011-08-16. Archived from the original on 2015-09-23. Retrieved 2015-10-05.
"Tuberculosis". December 9, 2011. Archived from the original on September 6, 2014. Retrieved September 6, 2013.
Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection Archived 2022-09-01 at the Wayback Machine. cdc.gov. updated November 22, 2013.
Maugh II, Thomas H. (2011-05-17). "Shorter treatment found for latent tuberculosis". Los Angeles Times. Archived from the original on 2022-08-19. Retrieved 2019-10-29. Although TB control measures in the United States have brought the incidence of the disease to an all-time low of 11,181 cases in 2010, it is estimated that at least 11 million Americans have latent TB. 'The 11 million Americans with latent TB represent a ticking time bomb,' Dr. Kenneth Castro, director of the Centers for Disease Control and Prevention's division of tuberculosis elimination, said at a news conference Monday. 'They're the source of future TB cases.'
McNeil, Donald G. Jr. (20 September 2018). "'Latent' tuberculosis? It's not that common, experts find". The New York Times. Archived from the original on 17 August 2022. Retrieved 13 March 2020.
Corrigenda (25 May 2022) Global tuberculosis report 2021 (PDF). World Health Organization. 14 October 2021. ISBN 978-92-4-003702-1. Archived (PDF) from the original on 8 August 2022. Retrieved 18 September 2022.

who.int

"Tuberculosis". World Health Organization. 2007. Archived from the original on 2009-11-11.
"WHO | Tuberculosis". Who.int. 2015-03-09. Archived from the original on 2012-08-23. Retrieved 2015-10-05.

cdn.who.int

Corrigenda (25 May 2022) Global tuberculosis report 2021 (PDF). World Health Organization. 14 October 2021. ISBN 978-92-4-003702-1. Archived (PDF) from the original on 8 August 2022. Retrieved 18 September 2022.

worldcat.org

search.worldcat.org

Jasmer R.M., Nahid P., Hopewell P.C. (2002). "Clinical practice. Latent tuberculosis infection" (PDF). The New England Journal of Medicine. 347 (23): 1860–1866. doi:10.1056/NEJMcp021045. ISSN 0028-4793. PMID 12466511. Archived from the original (PDF) on 2011-02-24.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (August 23, 2018). "Revisiting the timetable of tuberculosis". BMJ (Clinical Research Ed.). 362: k2738. doi:10.1136/bmj.k2738. ISSN 1756-1833. PMC 6105930. PMID 30139910.
Behr, Marcel A.; Edelstein, Paul H.; Ramakrishnan, Lalita (2019-10-24). "Is Mycobacterium tuberculosis infection life long?". BMJ. 367: l5770. doi:10.1136/bmj.l5770. ISSN 0959-8138. PMC 6812595. PMID 31649096.